Pharma Journalist 8791 posts 0 comments

SMi Group reports: 4th Annual Ophthalmic Drugs Conference taking place on the 22nd-23rd of November 2021, in London With 50% of the global population predicted to have complications…
Read More...

Pfizer Inc. and BioNTech SE announced that they have submitted Phase 1 data to the U.S. Food and Drug Administration (FDA) to support the evaluation of a third, or booster, dose of the…
Read More...

GlaxoSmithKline (GSK) plc announced the US Food and Drug Administration (FDA) approved a new indication for JEMPERLI (dostarlimab-gxly), a programmed cell death receptor-1 (PD-1)…
Read More...

HDT Bio Corp., a developer of immunotherapies for oncology and infectious diseases, announced an agreement with Korean biotech Quratis Inc. to co-develop HDT’s revolutionary COVID-19…
Read More...

Gritstone bio, Inc. a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, announced that the company entered into a funding…
Read More...

Nexus Pharmaceuticals, Inc., a U.S.-based healthcare company and domestic pharmaceutical manufacturer, has received a patent covering applications of EMERPHED Ready-To-Use Ephedrine…
Read More...

Aurinia Pharmaceuticals Inc. announced the addition of two novel assets that will expand the Company’s rare autoimmune and kidney-related disease pipeline. “Over the past year, in…
Read More...

Virpax Pharmaceuticals, Inc. a company specializing in developing product candidates for pain management, CNS and anti-viral indications, today announced that it has received a written…
Read More...

Marrone Bio Innovations, Inc. an international leader in sustainable bioprotection and plant health solutions to support global agricultural needs, and Terramera, a global agtech leader…
Read More...

Exelixis, Inc. and Invenra, Inc. announced that they have expanded their discovery and licensing collaboration to include an additional 20 oncology targets. The augmented partnership…
Read More...